A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.
A protein kinase linked to inflammation and tumor development may be a good target for gastric cancer therapies.
A protein normally known to promote cell death found to encourage survival of blood forming cells.
Vanderbilt investigators have identified how two key components of cancer’s invasive “switch” — the series of signaling events that turn on a tumor cell’s invasive behavior — work together.
A transcription factor called LIP is capable of causing one cell to consume another.
Targeting immune system proteins may keep prostate cancer from spreading to bone.
Accessibility Tools